Sky Century Investment (SKYI) Cash & Equivalents (2012 - 2026)
Sky Century Investment (SKYI) posted quarterly Cash & Equivalents of $264.0 for Q2 2026, down 97.67% year-over-year from $11312.0 in Q2 2025, and down 92.14% quarter-over-quarter from $3360.0 in Q1 2026.
Sky Century Investment (SKYI) Cash & Equivalents (2012 - 2026) Analysis & Trends
Sky Century Investment (SKYI) has reported Cash & Equivalents for 5 consecutive years, with $264.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Cash & Equivalents fell 97.67% year-over-year to $264.0; the TTM figure through May 2026 stood at $264.0 (down 97.67% YoY), while the FY2025 annual figure was $477.0, changed N/A from the prior year.
- Cash & Equivalents retreated to $264.0 in Q2 2026 per SKYI's latest filing, from $3360.0 in the prior quarter.
- Across five years, Cash & Equivalents topped out at $11312.0 in Q2 2025 and bottomed at $264.0 in Q2 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 1.11 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | 3.66 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 1.48 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 2.89 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | 1.80 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 886.50 Mn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 332.40 Mn |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | 530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 164.00 Mn |
| 10 | Sky Century Investment | 393,547.71 | 393,283.71 | 26,045.00 | 264.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 264.00 |
| Feb 28, 2026 | 3,360.00 |
| Nov 30, 2025 | 467.00 |
| Aug 31, 2025 | 477.00 |
| May 31, 2025 | 11,312.00 |
| Aug 31, 2014 | 515.00 |
| May 31, 2014 | 515.00 |
| Feb 28, 2014 | 515.00 |
| Nov 30, 2013 | 5,565.00 |
| Aug 31, 2013 | 479.00 |
| May 31, 2013 | 154.00 |
| Feb 28, 2013 | 154.00 |
| Nov 30, 2012 | 354.00 |
| Aug 31, 2012 | 854.00 |